SpineGuard SA (ALSGD.PA)
- Business Wire
SpineGuard Files Its "510K" Dossier in the US for the Clearance of Its New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion
PARIS & BOULDER, Colo., July 17, 2024--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces the filing of its "510K" regulatory dossier in the US with the FDA, seeking clearance to commercialize its new device designed to secure the Posterior sacroiliac Fusion (PsiF) surgical procedure.
- Business Wire
SpineGuard Announces its H1 2024 Revenue
PARIS & BOULDER, Colo., July 15, 2024--Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2024 revenue.
- Business Wire
SpineGuard Reports on Its Annual Shareholders’ Meeting of June 26, 2024
PARIS & BOULDER, Colo., June 26, 2024--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, publishes on its Annual Shareholders’ Meeting held on Wednesday June 26, 2024, convened on the second notice at the offices of the law firm Ashurst Paris, located at 18 square Edouard VII, 75009 Paris.
